# Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome

> **NCT00720694** · PHASE3 · COMPLETED · sponsor: **Storz Medical AG** · enrollment: 250 (actual)

## Conditions studied

- Plantar Fasciitis

## Interventions

- **DEVICE:** Duolith SD1
- **DEVICE:** Sham Duolith SD1

## Key facts

- **NCT ID:** NCT00720694
- **Lead sponsor:** Storz Medical AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-05
- **Final completion:** —
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2018-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00720694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00720694, "Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00720694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*